Thompson Siegel & Walmsley’s Imperva, Inc. IMPV Stock Holding History

Thompson Siegel & Walmsley’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-263	Closed	-$15K	–	792
2018 Q4	$15K	Sell	263 -246,153	-100%	-$13.4M	﹤0.01%	605
2018 Q3	$11.4M	Sell	246,416 -570	-0.2%	-$27.6K	0.15%	133
2018 Q2	$11.9M	Buy	+246,986	New	+$11.8M	0.15%	130

Thompson Siegel & Walmsley's IMPV Position: Q1 2019 in Review

Thompson Siegel & Walmsley sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 263 shares — an estimated $15K sold.

Thompson Siegel & Walmsley first reported a position in IMPV in Q2 2018 and held it in 3 quarters. The position peaked at $11.9M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

Thompson Siegel & Walmsley reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
Thompson Siegel & Walmsley sold 263 Imperva, Inc. shares in Q1 2019, an estimated $15K.
Thompson Siegel & Walmsley first reported a position in Imperva, Inc. in Q2 2018 and held it in 3 quarters.
Thompson Siegel & Walmsley's Imperva, Inc. position peaked at $11.9M in Q2 2018.
0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2019, filed 13 May 2019.